Antileishmanial Activity of Ampbotericin B Entrapped in Cationic Liposomal Formulation
Implementing Organization
Indian Institute of Chemical Engineers
Indian Institute of Chemical Biology (IICB)
About
A novel method of treatment of Kala Azar using medicament comprising of antileishmanial amphotericin B encapsulated in leishmaniacidal cationic liposome.
Patents
IN264798
Outcome / Output
The drug-loaded liposomes have enhanced efficacy as antileishmanial agents and provide improved therapeutic index as compared to the free drug; Safe and stable. Immense therapeutic potential.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Indian Institute of Chemical Engineers
Acces sibility Controls